Evidence map›Paper›PMID 19017967›Full record

ArticleJournal of immunology (Baltimore, Md. : 1950)2008

Egr2 is required for Bcl-2 induction during positive selection.

Jens-Peter Holst Lauritsen, Sridevi Kurella, Sang-Yun Lee, Juliette M Lefebvre, Michele Rhodes, José Alberola-Ila, David L Wiest

Open access · greenAbstract read
In one paragraph

Article in Journal of immunology (Baltimore, Md. : 1950), 2008. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 29 papers.

0numbers the graph read from it
0cells of the map it votes in
29citing papers in PubMed
1.5field-weighted citation impact, top 18% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

29 citing papers in PubMed, 40 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Bcl-2 Is Necessary to Counteract Bim and Promote Survival of TCRαβJournal of immunology (Baltimore, Md. : 1950) · 2022
    Article
  6. Article
  7. Development of αβ T Cells with Innate Functions.Advances in experimental medicine and biology · 2022
    Article
  8. Article
  9. ERK Signaling Controls Innate-like CD8Journal of immunology (Baltimore, Md. : 1950) · 2018
    Article
  10. Id3 Restricts γδ NKT Cell Expansion by Controlling Egr2 and c-Myc Activity.Journal of immunology (Baltimore, Md. : 1950) · 2018
    Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Egr2 and Egr3 in regulatory T cells cooperatively control systemic autoimmunity through Ltbp3-mediated TGF-β3 production.Proceedings of the National Academy of Sciences of the United States of America · 2016
    Article
  16. Article
  17. EGR2 is critical for peripheral naïve T-cell differentiation and the T-cell response to influenza.Proceedings of the National Academy of Sciences of the United States of America · 2014
    Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 2 institutions in 1 country.

Jens-Peter Holst LauritsenDivision of Basic Sciences, Immunobiology Working Group, Fox Chase Cancer Center, Philadelphia, PA 19111, USA.
Sridevi Kurella
Sang-Yun Lee
Juliette M Lefebvre
Michele Rhodes
José Alberola-Ila
David L Wiest
Fox Chase Cancer Center · USOklahoma Medical Research Foundation · US

Funding

WORD PROCESSING CENTER--COREP30CA006927 · NCI · RESEARCH INST OF FOX CHASE CAN CTR · PI Margaret von Mehren · 1985 to 2026
$138.8M
TRANSGENIC AND CHIMERIC MOUSE COREP30DK050306 · NIDDK · UNIVERSITY OF PENNSYLVANIA · PI Ken Hashigiwa Cadwell · 1997 to 2026
$32.5M
Role of Egr Proteins in Thymocyte DevelopmentR01CA100144 · NCI · RESEARCH INST OF FOX CHASE CAN CTR · PI WIEST, DAVID L. · 2004 to 2008
$1.7M
Role of GATA-3 During CD4/CD8 Lineage CommitmentR01AI059302 · NIAID · OKLAHOMA MEDICAL RESEARCH FOUNDATION · PI ALBEROLA-ILA, JOSE · 2005 to 2009
$1.7M
DEVELOPMENTAL CONTROL OF TCR EXPRESSION IN THYMOCYTESR29CA073656 · NCI · INSTITUTE FOR CANCER RESEARCH · PI WIEST, DAVID L · 1997 to 2001
$197k
NCI NIH HHS CA100144NCI NIH HHS CA73656NCI NIH HHS CA87407NCI NIH HHS P01CA06927NCI NIH HHS P30 CA006927NCI NIH HHS R01 CA100144NIAID NIH HHS AI059302NIAID NIH HHS R01 AI059302NIDDK NIH HHS P30 DK050306NIDDK NIH HHS P30-DK-50306
6 · The paper itself

Abstract

The repertoire of TCR specificities is established by a selection process in the thymus, during which precursor survival and maturation is dictated by the nature of the TCR signals. The differences in signals that determine whether precursors will survive and mature or be induced to die remain poorly understood. Among the molecular effectors involved in executing the differentiation process initiated by TCR-ligand interactions is a family of Zn-finger transcription factors termed early growth response genes (Egr). Indeed, ablation of the Egr1 gene impairs ligand-induced maturation (positive selection) but not ligand-induced deletion (negative selection). The partial impairment of positive selection by Egr1 deficiency is not enhanced by simultaneous deletion of another Egr family member, Egr3. Accordingly, we asked whether this results from compensation by another family member, Egr2. In this manuscript, we demonstrate that deletion of Egr2 impairs positive selection of both CD4 and CD8 single-positive thymocytes. Interestingly, many of the genes involved in positive selection and T cell differentiation are up-regulated normally in the Egr2-deficient thymocytes. However, Bcl-2 up-regulation is not sustained during late stages of positive selection. This defect is at least partially responsible for the developmental blockade in Egr2-deficient thymocytes, as enforced expression of Bcl-2 rescues T cell development in Egr2(-/-) thymocytes. Taken together, these data suggest that Egr2 plays a central role in the up-regulation of the survival molecule Bcl-2 during positive selection.

Indexed as

AnimalsCD4-Positive T-LymphocytesCD8-Positive T-LymphocytesCell DifferentiationCell SurvivalClonal DeletionEarly Growth Response Protein 1Early Growth Response Protein 2Lymphoid Progenitor CellsMiceMice, KnockoutProto-Oncogene Proteins c-bcl-2Receptors, Antigen, T-CellSignal TransductionThymus GlandUp-RegulationEarly Growth Response Protein 1Early Growth Response Protein 2Egr1 protein, mouseEgr2 protein, mouseProto-Oncogene Proteins c-bcl-2Receptors, Antigen, T-Cell

Identifiers

PMID19017967
PMCPMC2587029
OpenAlexW2168687675

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.